{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:13:47Z","timestamp":1772770427937,"version":"3.50.1"},"reference-count":28,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Scientific Research Common Program of the Beijing Municipal Commission of Education","award":["KM201810025021"],"award-info":[{"award-number":["KM201810025021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Aromatase plays a crucial role in the conversion of androgens to oestrogens and is often overexpressed in hormone-dependent tumours, particularly breast cancer. [18F]BIBD-071, which has excellent binding affinity for aromatase and good pharmacokinetics, has potential for the diagnosis and treatment of aromatase-related diseases. The MCF-7 cell line, which is hormone receptor-positive (HR+), was used in the assessment of the novel [18F]-labelled radiotracer [18F]BIBD-071 via positron emission tomography (PET) imaging of an HR+ breast cancer xenograft model. Methods: [18F]BIBD-071 was synthesised, radiolabelled, and then subjected to in vitro stability testing. MCF-7 cells were cultured and implanted into BALB\/c nude mice to establish subcutaneous tumour models. MicroPET\/CT imaging was conducted after injection of the tracer at 1 and 2 h, and a blocking study was also conducted using the aromatase inhibitor letrozole. A block experiment was used to prove the specificity of the probe. Biodistribution studies were performed at 0.5, 1, and 2 h post injection (p.i.). Immunofluorescence was used to assess aromatase expression in MCF-7 cells. Results: [18F]BIBD-071 showed excellent in vitro stability and specific uptake in an MCF-7 xenograft tumour model. MicroPET\/CT imaging at 1 and 2 h p.i. revealed excellent tumour visualisation with a favourable tumour-to-background ratio. Biodistribution data revealed high tracer uptake in the liver, small intestine, and stomach, with significant washout from the bloodstream and tumour over time. The tumour uptakes at 0.5 h, 1 h, and 2 h were 3.84 \u00b1 0.13, 2.5 \u00b1 0.17, and 2.54 \u00b1 0.32, respectively. The tumour uptake significantly decreased between 0.5 h and 1 h (p &lt; 0.0001), whereas there was no significant difference between 1 and 2 h. The tumour\/background ratios at 0.5 h, 1 h, and 2 h were 1.19 \u00b1 0.03, 1.12 \u00b1 0.17, and 1.42 \u00b1 0.11, respectively. Immunofluorescence confirmed robust aromatase expression in MCF-7 cells, which was correlated with [18F]BIBD-071 tumour uptake. Conclusions: [18F]BIBD-071 is a promising PET tracer for diagnosing and monitoring HR+ breast cancer, warranting further research into hormone-dependent cancers.<\/jats:p>","DOI":"10.3390\/ph18010066","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T07:59:42Z","timestamp":1736409582000},"page":"66","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utilisation of the Innovative [18F]-Labelled Radiotracer [18F]-BIBD-071 Within HR+ Breast Cancer Xenograft Mouse Models"],"prefix":"10.3390","volume":"18","author":[{"given":"Di","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100071, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100071, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyuan","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100071, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9201-2831","authenticated-orcid":false,"given":"Hongbin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100071, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-3827","authenticated-orcid":false,"given":"Zehui","family":"Wu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Brain Disorders, Capital Medical University, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100071, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","article-title":"Sources of estrogen and their importance","volume":"86","author":"Simpson","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yfrne.2015.10.001","article-title":"In vivo visualization of aromatase in animals and humans","volume":"40","author":"Biegon","year":"2016","journal-title":"Front. Neuroendocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"111321","DOI":"10.1016\/j.mce.2021.111321","article-title":"Regulation of aromatase expression: Potential therapeutic insight into breast cancer treatment","volume":"531","author":"Molehin","year":"2021","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"120412","DOI":"10.1016\/j.talanta.2019.120412","article-title":"PET probe with Aggregation Induced Emission characteristics for the specific turn-on of aromatase","volume":"208","author":"Wu","year":"2020","journal-title":"Talanta"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jendso\/bvab050","article-title":"19-hydroxy Steroids in the Aromatase Reaction: Review on Expression and Potential Functions","volume":"5","author":"Abaffy","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gonzalez-Mora, A.M., and Garcia-Lopez, P. (2021). Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212404"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/bs.pmbts.2016.10.002","article-title":"Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers: An Overview of Therapeutic Strategies","volume":"144","author":"Manna","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neulet.2004.07.010","article-title":"Aromatase, the enzyme responsible for estrogen biosynthesis, is expressed by human and rat glioblastomas","volume":"368","author":"Yague","year":"2004","journal-title":"Neurosci. Lett."},{"key":"ref_9","first-page":"9802086","article-title":"Aromatase Expression in the Hippocampus of AD Patients and 5xFAD Mice","volume":"2016","author":"Dudzinski","year":"2016","journal-title":"Neural Plast."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2826.2008.01713.x","article-title":"Aromatase in the brain: Not just for reproduction anymore","volume":"20","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Koninckx, P.R., Fernandes, R., Ussia, A., Schindler, L., Wattiez, A., Al-Suwaidi, S., Amro, B., Al-Maamari, B., Hakim, Z., and Tahlak, M. (2021). Pathogenesis Based Diagnosis and Treatment of Endometriosis. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.745548"},{"key":"ref_12","first-page":"189","article-title":"Aromatase in the Human Brain","volume":"2","author":"Azcoitia","year":"2021","journal-title":"Androg. Clin. Res. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s11010-021-04099-0","article-title":"Regulation of aromatase in cancer","volume":"476","author":"Molehin","year":"2021","journal-title":"Mol. Cell Biochem."},{"key":"ref_15","first-page":"297","article-title":"An in vivo model of intratumoural aromatase using aromatase-transfected MCF7 human breast cancer cells","volume":"62","author":"Lee","year":"1995","journal-title":"Exp. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Min, D.Y., Jung, E., Ahn, S.S., Lee, Y.H., Lim, Y., and Shin, S.Y. (2020). Chrysoeriol Prevents TNFalpha-Induced CYP19 Gene Expression via EGR-1 Downregulation in MCF7 Breast Cancer Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207523"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10555-008-9154-7","article-title":"Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography","volume":"27","author":"McConathy","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00280-013-2205-y","article-title":"The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis","volume":"72","author":"Dave","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2967\/jnumed.119.231589","article-title":"Initial Studies with (11)C-Vorozole PET Detect Overexpression of Intratumoral Aromatase in Breast Cancer","volume":"61","author":"Biegon","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2967\/jnumed.114.150383","article-title":"Aromatase imaging with [N-methyl-11C]vorozole PET in healthy men and women","volume":"56","author":"Biegon","year":"2015","journal-title":"J. Nucl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2967\/jnumed.110.087072","article-title":"PET of aromatase in gastric parietal cells using 11C-vorozole","volume":"52","author":"Ozawa","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2013.00068","article-title":"In vivo imaging of brain aromatase in female baboons: [11C]vorozole kinetics and effect of the menstrual cycle","volume":"12","author":"Pareto","year":"2013","journal-title":"Mol. Imaging"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2967\/jnumed.113.131474","article-title":"11C-cetrozole: An improved C-11C-methylated PET probe for aromatase imaging in the brain","volume":"55","author":"Takahashi","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Takahashi, K., Hosoya, T., Onoe, K., Mori, T., Tazawa, S., Mawatari, A., Wada, Y., Watanabe, Y., Doi, H., and Watanabe, Y. (2021). PET imaging of brain aromatase in humans and rhesus monkeys by (11)C-labeled cetrozole analogs. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-03063-8"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jlcr.1502","article-title":"18F-Labelled vorozole analogues as PET tracer for aromatase","volume":"51","author":"Erlandsson","year":"2008","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1021\/acs.molpharmaceut.2c00176","article-title":"Novel (18)F-Labeled PET Tracers Specific to Aromatase: Design, Synthesis, and Biological Evaluation","volume":"19","author":"Zheng","year":"2022","journal-title":"Mol. Pharm."},{"key":"ref_27","first-page":"885","article-title":"Procedure Guideline for Tumor Imaging with 18F-FDG PET:CT 1.0","volume":"47","author":"Delbeke","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0960-0760(97)80010-6","article-title":"Aberrant expression of aromatase in breast cancer tissues","volume":"61","author":"Harada","year":"1997","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/1\/66\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:25:31Z","timestamp":1759919131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/1\/66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["ph18010066"],"URL":"https:\/\/doi.org\/10.3390\/ph18010066","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]}}}